top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
mTOR Signaling in Metabolism and Cancer
mTOR Signaling in Metabolism and Cancer
Autore Huang Shile
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (204 p.)
Soggetto topico Medicine
Soggetto non controllato Acute Lymphoblastic leukemia
adhesion
Akt
basal cell carcinoma
biomarkers
cancers
cell metabolism
cell signalling
clinical trials
combination
eribulin
everolimus
Foxp3
head and neck cancer
hematologic malignancies
histone deacetylase
inhibitors
integrins
intestine
invasion
liver
melanoma
Merkel cell carcinoma
metabolism
mTOR
mTOR signaling
mTOR signalling
muscle
mutant genes
neuron
photodynamic therapy
phytochemicals
PI3K
PI3K/AKT/mTOR
prostate cancer
regulatory T cells
skin cancers
squamous cell carcinoma
synergy
T cells
targeted therapies
targeted therapy
tissue regeneration
TNBC
tumor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557107203321
Huang Shile  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
Autore Cavallaro Ugo
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (208 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ALDH1
ATAC-seq
B4GALT1
bevacizumab
bowel cancer
breast cancer
Cadherin 11
cancer stem cell
cancer stem cells
cancer therapy
cell adhesion molecule
chemo-resistance
chemoresistance
chemotherapy resistance
colon
colorectal
CSCs
dasatinib
early breast cancer
EC-8042
epithelial-mesenchymal transition
exosomes
genetic heterogeneity
genome-wide
HDAC inhibitors
head and neck squamous cell carcinoma
immunohistochemistry
L1CAM
lipid
LUAD
lung cancer
metabolism
neoadjuvant chemotherapy
NSCLC
oral cancer risk
oral epithelial dysplasia
oral squamous cell carcinoma
organoid
ovarian cancer
Ovarian cancer
RNA-seq
saracatinib
SNP array
solid cancer
SOX2
SRC
stem cell
therapeutic resistance
therapy resistance
TNBC
transcriptome
tumor progression
tumoroid
Wnt signaling
WNT signaling
β-catenin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti New Aspects of Cancer Stem Cell Biology
Record Nr. UNINA-9910557112003321
Cavallaro Ugo  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Prognostic and Predictive Markers in Cancer Progression
New Prognostic and Predictive Markers in Cancer Progression
Autore Costantini Susan
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (294 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato acetyltransferase
AKT
antigen processing machinery (APM) molecules
AR
biomarker
biomarkers
bladder cancer
blood
BRCA1/2
breast cancer
cancer
cancer immunotherapy
cancer prognosis
carcinogenesis
cardioncology
cardiotoxicity
castration-resistant prostate cancer (CRPC)
CD8+ T effector cells
chemo-/radio resistance
CSC
CTCs
cytokines
EMT
eribulin
genetic syndromes
genomic mutations
head and neck cancer
head and neck neoplasms
head and neck tumors
HRR
HUB nodes
human leukocyte antigen (HLA)
hyperglycemia
immune checkpoint inhibitor
K-RAS oncogene
laryngeal cancer
lifestyle habit
major histocompatibility complex (MHC)
MAPK
melanoma
melanoma resistance to MAPK/MEK inhibitors
metabolomics
metastasis
microRNA
miRNA
MSI2
mTOR
musashi 2
mutations
N-cadherin
n/a
NAA10
new metastasis
nivolumab
oncogene dependency
oral cancer
OSCC
pancreatic cancer
paraganglioma
PDL1
pheochromocytoma
PI3K
PI3KCA
prediction
prognosis
prostate cancer
PTEN
resistance to immune checkpoint inhibitors
selenoproteins
targeted therapies
therapeutic resistance
therapeutic target
TILs
TNBC
transcriptomics
tumor predisposition
WNT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557794803321
Costantini Susan  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Autore Stefanachi Angela
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (416 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato EGR-1
flavonoid
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
MDA-MB-231
MMP9
TNFα
pancreatic ductal adenocarcinoma
cyclodextrin inclusion complex
phase solubility studies
preformulation studies
biphenylnicotinamide derivatives
dual inhibitor
EGFR
VEGFR2
ligand-based pharmacophore
molecular docking
molecular dynamics
leukemias
doxorubicin
inflammation
drug delivery
tumor targeting
elastin-like polypeptide
cell penetrating peptide
matrix metalloproteinase
doxorubicin resistance
photosensitizer delivery system
PAMAM dendrimer
photodynamic therapy
cytotoxicity
phototoxicity
colorectal adenocarcinoma
dicarboximides
chemical synthesis
apoptosis
kinases
anticancer
gene profiling
SAR
biomarkers
colorectal cancer
early detection examination
liquid biopsy
personalized medicine
tumor treatment
exosomes
ctDNA
CTC
cytotoxic activity
pyrazole derivatives
MTT assay
ADMET analysis
single-crystal diffraction
FTIR spectroscopy
NMR spectroscopy thermogravimetric analysis
acute myelogenous leukemia
platelets
microparticles
γδ T cells
immunotherapy
tumor resistance
combination therapy
tumor microenvironment
immune checkpoint inhibitor
neuroblastoma
molecular iodine
cyclophosphamide
xenografts
metronomic therapy
tamoxifen
CYP2D6
MCF-7
Ishikawa cells
SERM
TNBC
uterotrophic
α-mangostin
poly(amidoamine) dendrimer
targeted drug delivery
biotin targeting
glioblastoma multiforme
squamous cell carcinoma
antiparasitic therapy
diclofenac
indomethacin
oleanolic acid derivative conjugates
NF-κB
Nrf2
MAPKs
PSN-1 cells
reactive oxygen species
glioblastoma
brain tumor
extracellular vesicles
pancreatic cancer
paclitaxel
clathrin
endocytosis
sulforaphane
nicotine
metalloproteinase-9
gastric cancer
cell invasion
Arylquin 1
colon cancer
tumor progression
azelastine
oxidative stress
autophagy
mitotic catastrophe
chronic myeloid leukemia
imatinib
tyrosine kinase
ketoconazole
P-glycoprotein
drug efflux transporter
non-small-cell lung cancer
cisplatin resistance
aldehyde dehydrogenase
isothiocyanates
disulfiram
epithelial to mesenchymal transition
aminopeptidase N
acetamidophenones
Schiff bases
semicarbazones
thiosemicarbazones
inhibition of proliferation
ISBN 3-0365-5927-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639990003321
Stefanachi Angela  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Towards New Promising Discoveries For Lung Cancer Patients : : a Selection of Papers From The First Joint Meeting On Lung Cancer of The Fhu Oncoage (Nice, France) and The Md anderson Cancer Center (Houston, Tx, Usa) / / Paul Hofman, Sendurai Mani, George Calin
Towards New Promising Discoveries For Lung Cancer Patients : : a Selection of Papers From The First Joint Meeting On Lung Cancer of The Fhu Oncoage (Nice, France) and The Md anderson Cancer Center (Houston, Tx, Usa) / / Paul Hofman, Sendurai Mani, George Calin
Autore Hofman Paul
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (230 p.)
Soggetto topico Medicine
Soggetto non controllato microRNAs
multiplexed
screening
education
non-smoker
image analysis
artificial intelligence
research
lung cancer
spatial analysis
optimization
fluorescence
geriatric assessment
geriatric interventions
TNBC
liquid biopsy
non-small cell lung cancer
integrated approaches
well-being
hormone-like action
EGFR mutations
reversal of EMT
tumor plasticity
immune profiling
macrophage
multiplexed methodologies
targeted treatment
techniques
immune-oncology
bioinformatics
MALAT1
long non-coding RNAs
CD8 T Cells
personal medicine
EGFR TKIs
lncRNA
hormones
elderly
interleukin-1? and immunometabolism
chromogenic
xenograft
metastasis
PD-1/PD-L1 checkpoint blockade
immunotherapy
molecular
cancer tissues
digital
NSCLC
immune blockade
lung adenocarcinoma
circulating tumor cells
brightfield
non-coding RNAs
older adults
cancer
tumor microenvironment
aging
rational therapy
ISBN 9783039214525
3039214527
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367760103321
Hofman Paul  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui